Literature DB >> 27990619

Doxorubicin and Liposomal Doxorubicin Differentially Affect Expression of miR-208a and let-7g in Rat Ventricles and Atria.

Jan Novak1, Jiri Sana2, Tibor Stracina3, Marie Novakova3, Ondrej Slaby2.   

Abstract

Anthracyclines use is limited by profound cardiotoxicity. Involvement of miRNAs in anthracycline-induced cardiotoxicity (AIC) is still not completely understood. Thus, the expression of AIC-related microRNAs was determined in rat atria and ventricles after doxorubicin (DOX) and liposomal doxorubicin (L-DOX) administration. Vehiculum, DOX or L-DOX were applied intraperitoneally in a single dose to male Wistar rats (3 groups: control, DOX and L-DOX, respectively). Rats were sacrificed after 24 h, and samples from left atrium (LA)/ventricle (LV) and right atrium (RA)/ventricle (RV) were obtained. Expressions of miR-208a, let-7g and snU6 were determined using qRT-PCR. In the control group, miR-208a was highly abundant in the atria compared to the ventricles and in the left-sided structures compared to the right-sided structures, while let-7g showed only atrio-ventricular gradient with predominant expression in the atria. Administration of both DOX and L-DOX resulted in 38.87 and 23.57% reduction in miR-208a expression in the LV (p = 0.028) and in 13.79 and 14.70% reduction in let-7g expression in the LA (p = 0.015), respectively. Acute administration of DOX/L-DOX alters expression of miR-208a in LV and of let-7g in LA. These changes may partly contribute to the development of AIC.

Entities:  

Keywords:  Cardiotoxicity; Doxorubicin; let-7g; lipodox; miR-208a; microRNAs

Mesh:

Substances:

Year:  2017        PMID: 27990619     DOI: 10.1007/s12012-016-9393-8

Source DB:  PubMed          Journal:  Cardiovasc Toxicol        ISSN: 1530-7905            Impact factor:   3.231


  6 in total

1.  Identification of a Diagnostic Set of Endomyocardial Biopsy microRNAs for Acute Cellular Rejection Diagnostics in Patients after Heart Transplantation Using Next-Generation Sequencing.

Authors:  Tereza Nováková; Táňa Macháčková; Jan Novák; Petr Hude; Július Godava; Víta Žampachová; Jan Oppelt; Filip Zlámal; Petr Němec; Helena Bedáňová; Ondřej Slabý; Julie Bienertová-Vašků; Lenka Špinarová; Jan Krejčí
Journal:  Cells       Date:  2019-11-06       Impact factor: 6.600

Review 2.  MiRNAs and circRNAs for the Diagnosis of Anthracycline-Induced Cardiotoxicity in Breast Cancer Patients: A Narrative Review.

Authors:  Roberto Rosenfeld; Silvia Riondino; Vincenzo Formica; Francesco Torino; Eugenio Martuscelli; Mario Roselli
Journal:  J Pers Med       Date:  2022-06-28

Review 3.  Non-coding RNAs in cancer therapy-induced cardiotoxicity: Mechanisms, biomarkers, and treatments.

Authors:  Wanli Sun; Juping Xu; Li Wang; Yuchen Jiang; Jingrun Cui; Xin Su; Fan Yang; Li Tian; Zeyu Si; Yanwei Xing
Journal:  Front Cardiovasc Med       Date:  2022-08-23

4.  Functional role of microRNA-500a-3P-loaded liposomes in the treatment of cisplatin-induced AKI.

Authors:  Suhua Zhang; Huaixin Sun; Weixin Kong; Bo Zhang
Journal:  IET Nanobiotechnol       Date:  2020-08       Impact factor: 1.847

Review 5.  Epigenetic Changes Associated With Anthracycline-Induced Cardiotoxicity.

Authors:  Marwa Tantawy; Frances G Pamittan; Sonal Singh; Yan Gong
Journal:  Clin Transl Sci       Date:  2020-08-28       Impact factor: 4.689

Review 6.  Regional Diversities in Fibrogenesis Weighed as a Key Determinant for Atrial Arrhythmogenesis.

Authors:  Cheng-Chih Chung; Chye-Gen Chin; Yung-Kuo Lin; Yao-Chang Chen; Wan-Li Cheng; Yung-Hsin Yeh; Yu-Hsun Kao; Yi-Jen Chen
Journal:  Biomedicines       Date:  2021-12-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.